Sign In
Last checked at 
15 Dec 2008 09:33
ο»Ώ
Β
Hutchison China MediTech Limited ("Chi-Med")Β
(AIM: HCM)
Director's Shareholding
London:Β Monday, 15Β DecemberΒ 2008:Β Chi-MedΒ was informedΒ onΒ 12 DecemberΒ 2008Β that MrΒ Christian Hogg,Β Executive Director andΒ Chief Executive OfficerΒ of Chi-Med, purchasedΒ 100,000Β ordinary shares of US$1.00Β each in Chi-Med (the "Shares") at a price ofΒ 40pΒ each onΒ 12 December 2008.
Following this purchase, MrΒ HoggΒ is beneficially interested inΒ 270,000Β Shares,Β representing approximately 0.5% of the current issued share capital of Chi-Med. This is in addition to the 576,136 vested options held by him,Β representing approximatelyΒ 1.1% of the current issued shareΒ capital of Chi-Med.
Ends
Enquiries
|
Chi-Med Christian Hogg, CEO |
Telephone: +852 2121 8200 |
|
Citigate Dewe Rogerson Anthony Carlisle David Dible |
Telephone: +44 (0) 20 7638 9571 +44 (0) 7973 611 888 +44 (0) 7967 566 919 |
About Chi-Med
Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily inΒ ChinaΒ and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.Β
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Follow the stocks
